Clinical Trials in Daegu, Dalseo Gu
2 recruiting
Showing 1–2 of 2 trials
Recruiting
A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea
Non-Small-Cell Lung Carcinoma
Novartis Pharmaceuticals250 enrolled12 locationsNCT05703516
Recruiting
A 24-week rPMS Study in Real-world Setting for Enerzair
Asthma
Novartis Pharmaceuticals600 enrolled16 locationsNCT05274425